BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 38462470)

  • 1. A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors.
    Iwamoto Y; Tatsumi F; Ohnishi M; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
    Medicine (Baltimore); 2024 Mar; 103(10):e37204. PubMed ID: 38457550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autopsy case: Pathological complete response in an advanced lung cancer patient with severe immune related adverse events and COVID-19.
    Moriya R; Kamihata N; Niwa Y; Kako H; Takahashi H; Kimura Y; Shigeyasu Y; Tsukamoto T; Hashimoto N; Imaizumi K
    Respir Investig; 2024 May; 62(3):438-441. PubMed ID: 38518583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe upper gastrointestinal disorders in pembrolizumab-treated non-small cell lung cancer patient.
    Onuki T; Morita E; Sakamoto N; Nagai Y; Sata M; Hagiwara K
    Respirol Case Rep; 2018 Aug; 6(6):e00334. PubMed ID: 30065841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory pembrolizumab immunotherapy-related colitis requiring biological therapy in an inactive HBcAb carrier.
    Rasheed N; Anand R; Maddox M; Reyes C
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37751983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors-Associated Generalized Lipodystrophy: Reconstructive Challenges of an Emerging and Distinct Form of Lipodystrophy.
    Kreutz-Rodrigues L; Cherukuri S; Rames JD; Chen A; Meira Pazelli A; Mardini S; Gibreel W
    J Craniofac Surg; 2024 Jun; ():. PubMed ID: 38869298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review.
    Barron CC; Stefanova I; Cha Y; Elsolh K; Zereshkian A; Gaafour N; McWhirter E
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37536939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
    Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
    Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
    Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
    Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review.
    Kitagawa S; Hakozaki T; Kitadai R; Hosomi Y
    Thorac Cancer; 2020 Jul; 11(7):1927-1933. PubMed ID: 32421224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
    Yamamoto T; Ito T; Hase T; Ishigami M; Mizuno K; Yamamoto K; Imai N; Ishizu Y; Honda T; Shibata H; Hatta T; Yogo N; Yasuda S; Toyoda H; Abe T; Kawashima H; Hashimoto N; Fujishiro M
    Cancer Invest; 2022 Feb; 40(2):189-198. PubMed ID: 34658277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of immune-related gastroesophagitis with laryngopharyngitis caused by immune checkpoint inhibitors in nonsmall cell lung cancer].
    Oka Y; Hamano Y; Nakamura R; Mabuchi K; Ochi M; Yamaguchi Y; Okawara H; Okawara A; Kakinoki N; Kamoshida T
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(3):221-229. PubMed ID: 38462470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review.
    Yuan-Di Wang ; Yuan S; Wen C; Ji Z; Xiang B; Wang B; Zhang Z
    Immunotherapy; 2023 Oct; 15(14):1117-1123. PubMed ID: 37431609
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.